Disclosure 0000907654-26-000087-2

SEC FORM 4

$599,556.03

Oruka Therapeutics, Inc. (ORKA)

Sale of 6,604 shares at $90.7868 per share.

Reporting Person Klein Lawrence Otto · Officer Title Chief Executive Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0000907654-26-000087 · filed 2026-09-01 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-09-01. https://desqlong.com/cards/0000907654-26-000087-2 (retrieved 2026-09-26).